Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Hemophilia B
Trial Locations (90)

1020

Brussels

1090

Vienna

Brussels

1200

Brussels

2650

Edegem

3000

Leuven

Coimbra

4420

Montegnée

11009

Cadiz

20162

Milan

20246

Hamburg

28046

Madrid

36100

Vicenza

38003

Santander

41013

Seville

43100

Parma

46009

Valencia

47010

Valladolid

48143

Münster

50009

Zaragoza

60100

Ancona

65100

Pescara

70124

Bari

80131

Napoli

88100

Catanzaro

89100

Reggio Calabria

90100

Palermo

90134

Palermo

91054

Erlangen

95124

Catania

80 80054

Amiens

49 49033

Angers

14 14033

Caen

73 73011

Chambéry

38 38043

Grenoble

78 78153

Le Chesnay

94 94279

Le Kremlin-Bicêtre

35 35340

Liffré

87 87042

Limoges

03 69437

Lyon

69 69000

Lyon

13 13385

Marseille

95 95160

Montmorency

34 34059

Montpellier

34 34295

Montpellier

44 44093

Nantes

58 58020

Nevers

06 06202

Nice

66 66344

Osséja

75 75674

Paris

75 75743

Paris

76 76031

Rouen

42 42270

Saint-Priest-en-Jarez

37 37044

Tours

07100

Sassari

Unknown

Padua

Plymouth

06126

Perugia

00161

Roma

1007 MB

Amsterdam

4818 CK

Breda

5623 EJ

Eindhoven

6229 HX

Maastricht

6525 GA

Nijmegen

3584 CX

Utrecht

04009

Almería

08035

Barcelona

09005

Burgos

08950

Esplugues de Llobregat

06800

Mérida-Badajoz

01004

Vitoria-Gasteiz

205 02

Malmo

171 76

Stockholm

TR1 3LJ

Truro

SE13 6LH

London

W12 0HS

London

WC1N 3JH

London

M27 4HA

Manchester

EH16 4SA

Edinburgh

L12 2AP

Liverpool

Sheffield

OX3 L7J

Oxford

S10 2TH

Sheffield

CF4 4XW

Cardiff

B4 6NL

Birmingham

WV10 0QP

Wolverhampton

L59 7FF

Leeds

E1 1BB

London

BH15 2JB

Poole

S10 2JF

Sheffield

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00167973 - Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use | Biotech Hunter | Biotech Hunter